Zydus Lifesciences Limited has informed the Exchange about press release dated 08-Nov-2022 titled Zydus receives final approval from the USFDA for Bisoprolol Fumarate and Hydrochlorothiazide Tablets
Press Release Nov 08 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
In the deck
Earlier from Zydus Lifesciences
- Press Release Nov 07 2022
- Press Release Nov 03 2022
- Press Release Oct 29 2022
- Press Release Oct 26 2022
- Press Release Oct 22 2022
Later from Zydus Lifesciences
- Press Release Nov 16 2022
- Press Release Nov 23 2022
- Press Release Nov 28 2022
- Press Release Dec 01 2022
- Press Release Dec 02 2022
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences